CDEK
← All drugs Report issue

technetium tc-99m sulfur colloid kit

Trade name: Tesuloid

Small moleculeapprovedImaging agent

Approved

Jun 10, 1974

Clinical trial activity

29 trials · 35 clinical orgs · 6 marketing orgs

Phase 1
2
Phase 2
7
Phase 3
0
Phase 4
3

Earliest trial started Sep 1, 1997 (NCT00003654)

Timeline

1970s

  1. Jun 10, 1974

    Bracco — Earliest FDA Approval

  2. Jun 10, 1974

    Bracco — NDA Secondary Org

  3. Jun 10, 1974

    Bracco — NDA Organization

  4. Sep 30, 1974

    Mallinckrodt — NDA Secondary Org

  5. Nov 18, 1976

    General Electric — NDA Secondary Org

  6. Apr 17, 1978

    Sun Pharmaceuticals — Marketing Organization

  7. Apr 17, 1978

    Pharmalucence — NDA Secondary Org

  8. Apr 17, 1978

    Sun Pharmaceuticals — NDA Secondary Org

2000s

  1. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Nov 9, 2023

    Jubilant DraxImage Inc. — Marketing Organization

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetOTHER

    Diagnostic agent

  • Unspecified targetRadiopharmaceutical

    Radiopharmaceutical

Approval history

  • approvedJun 10, 1974

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Oral, Parenteral
Availability
Prescription Only
Imaging
99-technetium

Oral

Yes

Parenteral

Yes

Topical

No

Sources

Also known as

  • 99mtc sulfur colloid
  • 99mtc-sulfur colloid
  • 99tc sulfur colloid
  • an-sulfur colloid
  • an-sulfur colloid kit
  • an-sulfur colloid kit
  • sulfur colloid
  • tc 99m sulfur colloid
  • tc 99m sulfur colloid
  • tc-99m sulfur colloid
  • tc-99m sulfur colloid
  • tc99m sulfur colloid
  • tc-sulfur colloid
  • technecoll
  • technecoll
  • technescan sulfur colloid
  • technescan sulfur colloid
  • technetium 99m sulfur colloid
  • technetium 99m sulfur colloid
  • technetium (99mtc) sulfur colloid
  • technetium (99mtc) sulfur colloid
  • technetium (99mtc) sulfur colloid
  • technetium sulfur colloid
  • technetium sulfur colloid
  • technetium tc 99m sulfur colloid
  • technetium tc 99m sulfur colloid
  • technetium tc 99m sulfur colloid
  • technetium tc-99m sulfur colloid
  • technetium tc-99m sulfur colloid
  • technetium tc-99m sulfur colloid
  • technetium tc-99m sulfur colloid
  • technetium tc-99m sulfur colloid kit
  • technetium tc-99m sulfur colloid kit
  • technetium tc-99m sulfur colloid kit
  • technetium tc 99m tsc
  • tesuloid
  • tesuloid
  • tesuloid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07121595Phase 2Jul 17, 2025University of Michigan
NCT03332940Phase 1Dec 6, 2017Navidea Biopharmaceuticals
NCT03199560Phase 4Jun 22, 2017Memorial Health University Medical Center
NCT02881554N/ADec 21, 2016National Cancer Institute (NCI), University of Washington
NCT02947126N/ANov 1, 2016National Heart, Lung, and Blood Institute (NHLBI), University of Pittsburgh
NCT02869152N/AAug 31, 2016University of Virginia
NCT02419807N/AFeb 17, 2015Case Western Reserve University, Mitaka USA, Inc., National Cancer Institute (NCI)
NCT02336737N/AJan 1, 2015Endomagnetics Inc, Regulatory and Clinical Research Institute Inc, University of California, San Francisco
NCT02287675Phase 4Oct 1, 2014Kettering Health Network
NCT02294565Phase 1/Phase 2 (Phase 2)Jun 1, 2014University of Texas at Houston, University of Utah, Vestan, Inc.
NCT02065232Phase 4Mar 1, 2014Navidea Biopharmaceuticals, University of California, San Diego
NCT01677338Phase 2Jul 1, 2013Covance, Otsuka
NCT01898403N/AJun 1, 2013National Cancer Institute (NCI), Stanford University
NCT02112240N/AMay 1, 2013American Cancer Society, Inc., University of Virginia
NCT01771666Phase 2Jul 31, 2012Stanford University
NCT01642511Phase 2Jan 1, 2012Shandong University
NCT01276054Phase 2Dec 1, 2010National Cancer Institute (NCI), University of Southern California
NCT01248221N/ADec 1, 2010Advanced Breath Diagnostics, LLC, Mayo Clinic, National Center for Research Resources (NCRR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00832429Phase 2Feb 25, 2009National Cancer Institute (NCI), University of Texas at Houston
NCT00743314N/ASep 1, 2008Mayo Clinic, National Cancer Institute (NCI)
Showing 20 of 29 trials
Page 1 / 2

Organizations

Research & Development (35)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government12121999
University of Texas at HoustonAcademic/Hospital3222005
Centre Paul StraussAcademic/Hospital2111997
Mayo ClinicAcademic/Hospital2212008
Navidea BiopharmaceuticalsFor profit2122014
Stanford UniversityAcademic/Hospital2222012
University of MiamiAcademic/Hospital2112002
University of VirginiaAcademic/Hospital2212013
Advanced Breath Diagnostics, LLCFor profit1012010
American Cancer Society, Inc.Academic/Hospital1012013
Case Western Reserve UniversityAcademic/Hospital1112015
CovanceFor profit1012013
Endomagnetics IncFor profit1112015
Gynecologic Oncology GroupAcademic/Hospital1112004
Kettering Health NetworkAcademic/Hospital1112014
Memorial Health University Medical CenterAcademic/Hospital1112017
Mitaka USA, Inc.For profit1012015
National Center for Research Resources (NCRR)Government1012010
National Heart, Lung, and Blood Institute (NHLBI)Government1012016
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government1012010
35 organizations
Page 1 / 2

Marketing (8)

OrganizationOrg typeRelationshipDate
BraccoFor profitNDA2Jun 10, 1974
BraccoFor profitNDAJun 10, 1974
General ElectricFor profitNDA2Nov 18, 1976
Jubilant DraxImage Inc.For profitMKTGNov 9, 2023
MallinckrodtFor profitNDA2Sep 30, 1974
PharmalucenceFor profitNDA2Apr 17, 1978
Sun PharmaceuticalsFor profitMKTGApr 17, 1978
Sun PharmaceuticalsFor profitNDA2Apr 17, 1978